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Summary
An altered activity of cellular functions is a general phenomenon observed in
several types of blood cells from asthrnatic patients, including eosinophils, monocytes
and T lymphocy'tes Ii-6]. In T lymphocy'tes from asthmatics the increment of activity is
reflected by increased expression of interleukin (IL)-2 receptor (CD25) and by enhanced
production of the (Th2-like) cy'tokines lL-3. 1L-4, 1L-5 and granulocyte/macrophage
colony-stimulating factor (GM-CSF). These cytokines are involved in both the early and
the late asthmatic reaction. IL-4 promotes B lymphocytes to produce IgE, which is
suppressed by the Thl-like cytokine IFN-gamma [7,8]. IL-3 is an important c1'tokine in
the production of mast cells from bone marrow progenitors. In addition. IL-3. IL-5 and
GM-CSF are responsible for the production. differentiation and activation of eosinophils.
Together these cytokines are regarded as the mediators of airway inflammation as
observed in asthma patients [9].  A possible explanation Íbr t l ie enhanced cel lular act ivi ty
and the aberrant cy,tokine gene expression may be an impairment of (a) negative-
regulatory signaling system(s). The cyclic-adenosine monophosphate (cAMP)-dependent
signaling pathway leading to activation of the protein kinase A (PKA) may be a
candidate, since activation of this signaling system results in inhibition of activating
signals and abrogates proliferation I I 0- I 2]. The PKA can be directly activated in viíro by
the cAMP analogue 2'-O-dibutyryl (db)-cAMP, but also indirectly by activation of cAMP
generating enzymes: the adenylyl cyclases. Adenylyl cyclases conveft ATP into cAMP
upon activation of certain G-protein coupled cell-surface receptors. Receptors attached
to this system are receptors for prostaglandins of the E type. as well as p-adrenergic
receptors. More recently, the cAMP dependent signaling pathway has been demonstrated
to be a negative regulator for cytokine gene expression. In particular, in T celi clones and
T cell lines the Thl-like cy'tokines IL-2 and interferon (lFN)-y were inl-ribited by the
concomitant activation of PKA. whereas the Th2-like cytokines IL-4 and IL-5 were not
afÍècted or even upregulated [3-17]. Previous studies l iave also demonstrated that
peripheral blood mononuclear cel ls f iom asthmatic patients generate lower levels of
intracel lular cAMP after a bronchial al lergen chal lenge. r,vhereas no impairment of cAMP
production was observed in astl-rn-ratic patients in a stable phase of their disease [18-22).
The impairment of adenylyl cyclase activity was already observed 3 hours atfer allergen
challenge 123,241. A dysfunctional adenylyl cyclase system results in lower levels of
intracellular cAMP and may theoretically lead to a diminrshed negative feedback controi
on cy.tokine gene expression.
'Ihe questions addressed in the present str-rdies are: i) is activation of the cAMP
dependent signaling pathway able to modulate cy.tokine gene expression in activated T
lymplrocl.tes (chapters 2 -5), ii) is the rnodulation in asthmatic subjects different from
healthy controls (chapter 8), and iii) is the observed Th2-like cy'tokine pattern in
asthmatic patients a result of a dysfunctional adenylyl cyclase system after allergen
provocation (chapler 9), or are other fàctors involved in the induction of a 1'h2-like
response (chupters 6, 7)?
Tlie effèct of actir,'ation of the adeni,lyl cyclase system on T lymphocy'te derived
cl.tokines was studied with B-adrenergic agonists. as an exarnple of the influence of the
adrenal gland-derived hormone epinephrine. In addition, prostaglandin E, (PGE,) was
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In chapter 2. we have examined the modulating effects of the cAMP dependent
signaling pathway on the expression of IL-3 and GM-CSF in activated human T
lymphocy.tes. Db-cAMP, PGE2. isoproterenol or isobutyl-methyl-xantin (IBMX)
costimulated with concanavalin A (Con A) or Con A plus the phorbolester phorbol
myristate acetate (PMA) inhibited IL-3 and GM-CSF mRNA accumulation compared to
the effects of Con A or Con A plus PMA alone. Nuclear run on experiments revealed
that the inhibitory effect of db-cAMP could partially be ascribed to a fivefold reduction
in transcription rate of both the IL-3 and GM-CSF gene in the presence of Con A or Con
A plus PMA. mRNA stability studies demonstrated that PMA increased the stability of
both transcripts. Db-cAMP did not affect the stability of IL-3 and GM-CSF mRNAs in
Con A activated cel ls. In contrast. in Con A plus PMA activated cel ls db-cAMP
significantly reduced the half-liÍè of both transcripts. Finally, it w,as shown that in
accordance with mRNA levels db-cAMP, PGE, and isoproterenol reduced the secretion
of IL-3 and GM-CSF protein in Con A and Con A plus PMA activated cel ls. In con-
clusion. these data demonstrate that the PKA dependent signal ing pathway is an
important regulatory mechanism in control ing IL-3 and GM-CSF gene expression
in activated human T lymphocytes.
In chapter 3, we have investigated the involvement of the cAMP- dependent
signaling pathway on IL-4 gene expression in fieshly isolated human T lymphocl'tes. Db-
cAMP and PGE, were used to directly and indirectly activate the PKA pathway.
Northern analysis revealed that Con A-, anti-CD3-. or anti-CD3 plus anti-CD28 (anti-
CD3/anti-CD28)-induced accumulation of IL-4 mRNA was inhibited by db-cAMP. Db-
cAMP showed a steep dose-dependent inhibition: concentrations < l0'u M did not affect
IL-4 mRNA accumulation. ln contrast. GM-CSF mRNA expression showed a wider
dose-dependent range: 10 5 M db-cAMP sti l l  affected GM-CSF accumulation.
PGE, inhibited the Con A- and anti-CD3/anti-CD28-induced accumulation of IL-4
mRNA in a dose-dependent fasl-r ion. Con A-induced IL-4 mRNA was inhibited by l0'a-
10-? M PGE,, anti-CD3/anti-CD28-induced IL-4 rRNA r.vas inhibited by 10 '-  l0 8 M
PGE,. Nuclear nln-on experirnents revealed tl-rat he inhibitory efÍècts of db-cAMP and
PGE, were accomplished at transcript ional evel in Con A-activated T cel ls, whereas
changes at transcript ional and posttranscript ional level were involved in anti-CD3lanti-
CD28-activated-f lyrnphocytes. In contrast to Clon A and anti-CD3/anti-CD28
activation. PMA plus A231S7-induced IL-4 mRNA expression was insensit ive to the
inhibitory effect of db-cAMP and PGE,, indicating that additional signaling pathways
might be triggered to circumvent IL-4 niRNA dor.vnregulation. Flowever, this could not
be mimicked by st imulat ing T lymphocytes with lL-2,1L-7,IL-i0, I I-12 or combination
of these cytokines in the presence of anti-CD3lanti-CD28. Finally, it was shown that in
accordance with the mRNA studies db-cAMP and PGE,, suppressed the IL-4 secretion in
Con A- and anti-CD3ianti-CD28-activated T cells. In conclusion, these data demonstrate
that IL-4 gene expression is negatively regulated by the PKA dependent signaling
pathway by transcript ional and posttranscript ional mechanisms depending on
costimulatory signals.
PKA activation is documented to be inhibitorv for Thl- l ike cy.tokines (IL-2,
t49
y), whereas Th2-like cy'tokines (lL-4, IL-5) are not affected or upregulated. In chapter 3
we have shown that IL-4 gene expression can be inhibited by PKA activation, but it
depends on the mode of T cell activation. For IL-5 gene expression we hypothesized that
the mode of T cell activation also determines the ultimate effect of simultaneous PKA
activation. The objective of chapler 4 was to examine IL-5 gene expression in T
lymphocy,tes Íiom healthy controls activated with various mitogenic stimuli, after
simultaneous activation of PKA by db-cAMP or PGE,. IL--5 mRNA was measured by
semi-quantitative reverse transcriptase-polymerase chain reaction (RT-PCR) or by
Northern analysis. IL-5 protein was measured by ELISA. Transcriptional mechanisms
involved in IL-5 gene expression were determined by nuclear run-on experiments and
electrophoretic mobility shift assays (EMSA). Posttranscriptional mechanisms were
determined by actinomycin D chase studies. The results demonstrate that anti-CD2-,
anti-CD3- and anti-CD3/anti-CD28-induced IL-5 mRNAs were completely inhibited by
db-cAMP ( 10 3M) and PGE, ( l0 5M), whereas Con A-induced IL-5 mRNA was part ial ly
reduced. The effect of PGE, was accomplished at the transcriptional level, probably due
to inhibition of DNA binding of nuclear factor-xB Q\F-rcB). anti-CD3/anti-CD28-
induced IL-5 protein was signif icantly reduced by PGE, (p<0.001). Addit ion of
cytokines which use the IL-2 receptor y.-chain ( lL-2. IL-7 .IL-I5) abrogated the PGE,
induced inhibition of IL-5 protein. In contrast. Con A plus PMA-induced IL-5 protein
was significantly r,rpregulated by the simultaneous addition of PGE, (p<0.03). We
conclude that PKA activation differentially modulates IL-5 gene expression, and
this depends on the mode of T cel l  act ivat ion.
Cyokine gene expression in T lymphocy'tes is a strictly regulated process,
involving both stimulatory and inhibitory signals. p-Adrenoceptor (BAR) agonists are
widely used in the treatment of asthma and are able to induce an inhibitory signal on
inrmunological responses after binding to their specific receptors. In chapter J, the
characterization of pAR subtype(s) (P r, p,, and pr) involved in the regulation of IL-3,
IL-4, GM-CSF and IFN-y mRNA accumulation was studied by using various pAR
agonists and antagonists. Con A-induced IFN-y, GM-CSF and IL-3 mRNAs are dose-
dependently inhibited by the nonselective pAR agonist isoproterenol and by the selective
prAR agonist fenoterol. lL-4 mRNA accumulation was not susceptible to pAR
stimulat ion. The observed inhibit ion or-r IFN-y, GM-CSF, and IL-3 mRNA was blocked
b y t h e s e l e c t i v e p r A R a n t a g o n i s t l c l  1 1 8 , 5 5 1  ( 1 0 6 M ) a n d  b y  t i m o l o l ( 1 0 - Ó M ) , a n o n -
selective antagonist.  The selective p,AR antagonist atenolol 10.3 x 10 6 M; did not have
any effèct. Secretion of GM-CSF protein in the presence of increasing concentrations of
isoproterenol followed a sirnilar pattern as observed for GM-CSF mRNA. In addition,
the BAR mediated inhibit ion of IFN-y, GM-CSF, and IL-3 mRNA accumulation and
GM-CSF protein secretion were related to the accumulation of intracellular cAMP
levels. Altliough prAR mRNA was detectable in Con A-activated T lymphocytes, we
could not demonstrate a functional activity in the regulation of cytokine expression: the
ÊrAR agonist BRL 37344 had no effect on the accumulation of the studied cytokine
mRNAs, and did not signiÍicantly affect cellular cAMP levels. These data demonstrate
that p-agonist- induced inhibit ion of IFN-y, GM-CSF and IL-3 mRNA
accumulation is solely mediated tly Br-adrenoceptors.
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dIL-4 in human T
lymplrocytes was investigated.IL-7 alone did not induce IFN-y or IL-4 mRNA.
However, IL-7 dose-dependently Lrpregulates the anti-CD3- or anti-CD3/anti-CD28-
induced IFN-y and IL-4 mRNA expression. Used at an optimal concentration, IL-7 (5
ngiml-) increased the accumulation of IFN-y (8-fold) and IL-4 (2.5-fold) mRNAs, which
could not be blocked by al l-12 monoclonal antibodies (mAbs). The enhanced IFN-y
mRNA accumulation was observed within 3-6 h, without altering the pattern of the
kinetics. However. longer exposur'È (>12 h) did not resuh in dif fèrent IFN-y expression
for anti-CD3lanÍi-CD28 versus anti-CD3/anti-CD28 plus IL-7 st imulated T-
lymplrocl.tes. rRNA stability studies revealed thatIL-7 stabilizes both IFN-y and IL-4
mRNA transcripts. Nuclear run-on assays revealed that the transcription rate of the IFN-
y gene increased approximately 2-fold in the presence of IL-7. without affecting the
transcription rate of the IL-4 gene. The lL-7-mediated IFN-y upregulation could not be
inhibited by cycloheximide treatment in contrast to tL-4 gene expression. However. the
promotive effect of lL-7 on IFN-y and IL-4 gene expression could be blocked by genist-
ein and cyclosporin A. Finally, it was demonstrated that the effect of IL-l on IFN-y
mRNA accumulatiotr was also reflected at the protein level. In summary, these data
demonstrate that IL-7 preferentially upregulates IFN-y expression in activated T-
lymphocytes.
A similar study with IL-15 was perlbrmed rn chupler 7. IL-15 was examined for
i ts abi l i ty to modulate the expression of IFN-y and IL-4 in act ivated hr"rman T
lymphocytes. The eÍÍect of l l --15 was comparecl u, i t l i  I [ ,-2 and IL-7. o,tokines al l  known
to Llse the IL-2 receptor y..chain. ' l -he results dernonstrate that the extent of upregulat ion
of IFN-y and IL-4 rRNA was dependent on the applied cytokine ( lL-2 > IL-15 > lL-7)
and on the st imulatory signal. IFN-y i ind IL.-4 nrRNAs were upregulated by IL-15 in
Con A- and anti-CD3/anti-CD28-st imulated T lymphocytes. IFN-y mRNA accumulati-
otr,  but not lL-4 mRNA, was addit ivelv upregulated by I l--15 plus IL-7 in anti-CD3-
stimulated T ll,nrphocytes, and bl,passed the requirer.nent of CD28 signaling. FACS
sort ing experiments demonstrated that IFN-y rnRNA was upregulated by IL-15 in both
CD4+ and CD8+ T lymphocytes, whereas IL-4 mRNA accumulation predominantly
occurred in CD4+ cel ls. Preincr-rbation of highl,v puri t ied CD4+ T lymphocy'tes during 7
days with IL-15 arrd/or l t--7, fbl lorved by activation, also shorved enhanced IL-4 protein
secretion. but predominar-rtly upregulated IFN-y protein secretion. The net effect was a
drarnatical ly increased IFN-y/l l -4 rat io. Taken togetl ier. IL-15 and IL-7 can act as
costimulatory signals, which may favour a Thl immune response, part icularly in
the absence of suff icient CD28 costimulat ion.
Peripheral blood mononuclear ccl ls of asthnrer patients lack the potentiat ion of the
adenylvl cyclase syslem normall l '  observed in healthv cclntrol cel ls. In chupler 8. IFN-y.
IL-4 and I l--5 nrRNA expression and i ts control by' PGE. were examined in anti-
CD3/anti-C'D28-activatecl peripheral T lynrphocl ' tes obtained f iom S asthmatics and 4
healthy controls. In contrast to IFN-y mRNA. IL-zl and I i--5 nrRNAs were signif icantly
enhanced in the patient group in comparison with controls. hr addit ion. IL-5 showed a
significant itrverse correlation with FEV,, r,,r'hereas IL-4 positively correlated with
PC,omethacholine. IFN-y, IL-4 and IL-5 mlLNA accumulations were significantly
dirninished by l0-a M and l0 5 M PGE2 in both asthmatics and controls. IFN-y and IL-4
mRNAs were st i l l  signif icantl l 'dinrinislred by l0 6 M PGE, in controls, whereas IL-4
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mRNA was not significantly diminished in asthmatics. However, no significant
differences were observed between the asthma group and the control group with respect
to sensitivity for 10 Ó M PGE2. Our results demonstrate that activated peripheral blood
T lymphocytes from asthma patients display higher levels of IL-4 and IL-5 mRNA,
which may be due to a dysfunctional adenylyl cyclase.
The adenylyl cyclase system of asthma patients has been demonstrated to be
dysfunctional after allergen provocation, which resulted in a 40-500Á decreased
generation of intracellular cAMP.In chapter 9, we investigated whether a dysfunctional
adenylyl cyclase system after allergen provocation is responsible for an imbalanced
Th1/Th2 cy'tokine pattern as observed in asthrna. To this aim, peripheral blood T cells of
7 asthma patients were isolated before, 3 hours and 24 hours after allergen provocation,
and stimulated with anti-CD3/anti-CD28 monoclonal antibodies in the absence and
presence of isoproterenol and PGE2 to activate the adenylyl cyclase system. IL-5 and
IFN-y mRNAs were detected by semi-quantitative RT-PCR. The results show that
before allergen provocation, 10 5 M isoproterenol significantly downregulated IFN-y
mRNA, and showed a trend to upregulate IL-5 mRNA. After allergen provocation,
isoproterenol was not longer able to modulate IFN-y and IL-5. In contrast to the
observations with isoproterenol. PGE, still dose-dependently inhibited IFN-y mRNA,
both before, 3 hours and24 hours after allergen provocation. Surprisingly, IL-5 mRNA,
but not IFN-y mRNA, was significantly upregulated in anti-CD3/anti-CD28-activated T
cells 24 hours after allergen provocation, compared to before allergen provocation. We
conclude that al lergen provocation may result in abrogation of p-adrenergic control
: ï . . troUtne 
expression, which coincides with a selective priming of IL-5 producti-
General di.scussion
PBMCs frorn asthma patier-rts have diminished intracellular cAMP levels after
allergen challenge in comparison with healthy control subjects. This observation may
explain the disturbed Thl/Th2balance in favour of Th2 cytokines found in asthmatics.
However, from the literature a problem emerges. According to some studies on T cell
lines and T cell clones, Thl-like cl.tokines are downregulated, whereas Th2-like
cfokines are upregulated in response to cAMP elevations [1 5- 1 7]. Thus. decreased
levels of cAMP implicate less inhibit ion on Thl- l ike and less upregulat ion of Th2-l ike
cy'tokines. The net effect could even be no eÍfect otr the Thl/Th2 ratio.'fheoretically. a
decreased ThllTh2 ratio can be expected in case of inhibition of 'Ih1-like cytokines by
the cAMP-dependent signaling path lr,ay in combination with no effect (or less inhibitory
effect) of the cAMP dependent signaling pathw'a1, on Th2-like cytokine gene expression
[ 1  3 ,  1  4 ] .
Because of the contradict ing f indings u' i th respect to Th2-l ike cytokine gene
expression in cell lines and clones (upregulation/no etfect), the main question adressed in
chapters 2-5 is whether Th2-like cytokine gene expression in peripheral T lymphocy'tes
from healthy controls are subject to modulation by the cAMP-dependent signaling
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